The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway

The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway

Kelch-like ECH-associated protein 1 (Keap1) is a ubiquitin E3 ligase specificity factor that targets transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) for ubiquitination and degradation. Disrupting Keap1-Nrf2 interaction stabilizes Nrf2, resulting in Nrf2 nuclear accumulation,...

Full description

Bibliographic Details
Main Authors:	Megan R. Edwards, Britney Johnson, Chad E. Mire, Wei Xu, Reed S. Shabman, Lauren N. Speller, Daisy W. Leung, Thomas W. Geisbert, Gaya K. Amarasinghe, Christopher F. Basler
Format:	Article
Language:	English
Published:	Elsevier 2014-03-01
Series:	Cell Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211124714000771

Similar Items

Deep Sequencing Identifies Noncanonical Editing of Ebola and Marburg Virus RNAs in Infected Cells
by: Reed S. Shabman, et al.
Published: (2014-12-01)

Role of K‑Loop Cysteine Residues in the Marburg Virus Protein VP24–Human Keap1 Complex
by: Nisha Bhattarai, et al.
Published: (2018-12-01)

Marburg Virus VP30 Is Required for Transcription Initiation at the Glycoprotein Gene
by: Megan R. Edwards, et al.
Published: (2022-10-01)

Filoviral Immune Evasion Mechanisms
by: Christopher F. Basler, et al.
Published: (2011-09-01)

Ebola virus VP30 and nucleoprotein interactions modulate viral RNA synthesis
by: Wei Xu, et al.
Published: (2017-06-01)

Postexposure Treatment of Marburg Virus Infection
by: Thomas W. Geisbert, et al.
Published: (2010-07-01)

Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates.
by: Chad E Mire, et al.
Published: (2014-01-01)

Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24
by: Palaniappan Ramanathan, et al.
Published: (2023-04-01)

An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions
by: Daisy W. Leung, et al.
Published: (2015-04-01)

A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge
by: Courtney Woolsey, et al.
Published: (2019-09-01)

Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers
by: William Wan, et al.
Published: (2020-10-01)

Cheminformatics Strategies Unlock Marburg Virus VP35 Inhibitors from Natural Compound Library
by: Isra M. Alsaady, et al.
Published: (2023-08-01)

The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.
by: Kari A Dilley, et al.
Published: (2017-01-01)

Modular mimicry and engagement of the Hippo pathway by Marburg virus VP40: Implications for filovirus biology and budding.
by: Ziying Han, et al.
Published: (2020-01-01)

Isolation and Characterization of a Novel Gammaherpesvirus from a Microbat Cell Line
by: Reed S. Shabman, et al.
Published: (2016-02-01)

Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats
by: Anitha D. Jayaprakash, et al.
Published: (2023-01-01)

Structural and Dynamical Basis of VP35-RBD Inhibition by Marine Fungi Compounds to Combat Marburg Virus Infection
by: Abdullah S. Alawam, et al.
Published: (2024-01-01)

Ebola and Marburg virus VP35 coiled-coil validated as antiviral target by tripartite split-GFP complementation
by: Luca Zinzula, et al.
Published: (2022-11-01)

Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress.
by: Jingjing Liang, et al.
Published: (2017-01-01)

Viral Targeting of Importin Alpha-Mediated Nuclear Import to Block Innate Immunity
by: Olivia A. Vogel, et al.
Published: (2023-12-01)

An upstream open reading frame modulates ebola virus polymerase translation and virus replication.
by: Reed S Shabman, et al.
Published: (2013-01-01)

Correction: Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress.
by: Jingjing Liang, et al.
Published: (2017-07-01)

Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism.
by: Shridhar Bale, et al.
Published: (2012-09-01)

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
by: Axel T. Lehrer, et al.
Published: (2021-08-01)

A computerized pharmaceutical repurposing approach reveals Semicochliodinol B synthesized from Chrysosporium merdarium as a viable therapeutic contender for Marburg virus's VP35 and VP40 proteins
by: Mahamudul Hasan, et al.
Published: (2022-01-01)

Mutation of Hydrophobic Residues in the C-Terminal Domain of the Marburg Virus Matrix Protein VP40 Disrupts Trafficking to the Plasma Membrane
by: Kaveesha J. Wijesinghe, et al.
Published: (2020-04-01)

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
by: Courtney Woolsey, et al.
Published: (2022-05-01)

Identification of a novel small-molecule Keap1–Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy
by: Cheng-Shi Jiang, et al.
Published: (2018-01-01)

An introduction to the Marburg virus vaccine consortium, MARVAC.
by: Robert W Cross, et al.
Published: (2022-10-01)

An introduction to the Marburg virus vaccine consortium, MARVAC
by: Robert W. Cross, et al.
Published: (2022-10-01)

Kant and Marburg School
by: Valeriy Ye. Semyonov
Published: (2023-09-01)

Etymologia: Marburg Virus
by: Ronnie Henry, et al.
Published: (2017-10-01)

Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
by: Chad E Mire, et al.
Published: (2013-01-01)

Die Bibliothekspartnerschaft Marburg-Sibiu
by: Riana Bucșă, et al.
Published: (2023-09-01)

Marburg virus outbreaks in Africa
by: Ibrahim Idris, et al.
Published: (2023-07-01)

Pathogenicity and virulence of Marburg virus
by: Mehedy Hasan Abir, et al.
Published: (2022-12-01)

Marburg virus and the disease it causes
by: Vladimir A. Markin
Published: (2022-12-01)

The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking
by: Angela R. Harrison, et al.
Published: (2021-08-01)

Marburg virus evades interferon responses by a mechanism distinct from ebola virus.
by: Charalampos Valmas, et al.
Published: (2010-01-01)

Marburg Virus and Monkeypox Virus: The Concurrent Outbreaks in Ghana and the lesson learned from the Marburg Virus Containment
by: Ranjit Sah, et al.
Published: (2022-12-01)